Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway

BioFactors

Volumn 35, Issue 1, 2009, Pages 76-81

  Himpe, Eddy ^a   Kooijman, Ron ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Activator of transcription; Insulin like growth factor I; JANUS kinase; Signal transducer; Signaling; Suppressor of cytokine signaling

Indexed keywords

CYTOKINE INDUCED INHIBITOR OF SIGNALING PROTEIN; INHIBITOR PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL KINASE; SOMATOMEDIN C RECEPTOR; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; CYTOKINE;

BODY GROWTH; CELL PROLIFERATION; CELL SURVIVAL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; HUMAN; METABOLISM;

ANIMALS; CYTOKINES; HUMANS; JANUS KINASES; MODELS, BIOLOGICAL; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 65549119187     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.20     Document Type: Review

References (58)

1. DeChiara, T.M., Efstratiadis, A., and Robertson, E. J. (1990) A growthdeficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345, 78-80.
2. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A. (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 72-82.
3. Liu, J. L. and LeRoith, D. (1999) Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140, 5178-5184.
4. Dupont, J. and Holzenberger, M. (2003) Biology of insulin-like growth factors in development. Birth Defects Res. C Embryo Today 69, 257-271.
5. Benito, M., Valverde, A. M., and Lorenzo, M. (1996) IGF-I: a mitogen also involved in differentiation processes in mammalian cells. Int. J. Biochem. Cell Biol. 28, 499-510.
6. Kooijman, R. (2006) Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev. 17, 305-323.
7. Firth, S. M. and Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocrinol. Rev. 23, 824-854.
8. Nakae, J., Kido, Y., and Accili, D. (2001) Distinct and overlapping functions of insulin and IGF-I receptors. Endocrinol. Rev. 22, 818-835.
9. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C. T. Jr. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol. Rev. 16, 143-163.
10. Laviola, L., Natalicchio, A., and Giorgino, F. (2007) The IGF-I signaling pathway. Curr. Pharm. Des. 13, 663-669.
11. Heron-Milhavet, L., Karas, M., Goldsmith, C. M., Baum, B. J., and LeRoith, D. (2001) Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair. J. Biol. Chem. 276, 18185-18192.
12. Krause, D., Lyons, A., Fennelly, C., and O'Connor, R. (2001) Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor-I receptor can be suppressed by dicumarol. J. Biol. Chem. 276, 19244-19252.
13. Galvan, V., Logvinova, A., Sperandio, S., Ichijo, H., and Bredesen, D. E. (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J. Biol. Chem. 278, 13325-13332.
14. Kim, A. H., Khursigara, G., Sun, X., Franke, T. F., and Chao, M. V. (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell Biol. 21, 893-901.
15. Aikin, R., Maysinger, D., and Rosenberg, L. (2004) Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 145, 4522-4531.
16. Buckley, D. A., Cheng, A., Kiely, P. A., Tremblay, M. L., and O'Connor, R. (2002) Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP- 1B-deficient fibroblasts. Mol. Cell Biol. 22, 1998-2010.
17. Hayashi, K., Shibata, K., Morita, T., Iwasaki, K., Watanabe, M., and Sobue, K. (2004) Insulin receptor substrate-1/SHP-2 interaction, a phenotype- dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J. Biol. Chem. 279, 40807-40818.
18. Keniry, M. and Parsons, R. (2008) The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27, 5477-5485.
19. Sasaoka, T., Kikuchi, K., Wada, T., Sato, A., Hori, H., Murakami, S., Fukui, K., Ishihara, H., Aota, R., Kimura, I., and Kobayashi, M. (2003) Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Endocrinology 144, 4204-4214.
20. O'Connor, R. (2003) Regulation of IGF-I receptor signaling in tumor cells. Horm. Metab. Res. 35, 771-777.
21. Kisseleva, T., Bhattacharya, S., Braunstein, J., and Schindler, C. W. (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285, 1-24.
22. Yadav, A., Kalita, A., Dhillon, S., and Banerjee, K. (2005) JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J. Biol. Chem. 280, 31830-31840.
23. Takahashi, T., Fukuda, K., Pan, J., Kodama, H., Sano, M., Makino, S., Kato, T., Manabe, T., and Ogawa, S. (1999) Characterization of insulinlike growth factor-1-induced activation of the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 85, 884-891.
24. Zong, C. S., Chan, J., Levy, D. E., Horvath, C., Sadowski, H. B., and Wang, L. H. (2000) Mechanism of STAT3 activation by insulin-like growth factor I receptor. J. Biol. Chem. 275, 15099-15105.
25. Ebong, S., Yu, C. R., Carper, D. A., Chepelinsky, A. B., and Egwuagu, C. E. (2004) Activation of STAT signaling pathways and induction of suppressors of cytokine signaling (SOCS) proteins in mammalian lens by growth factors. Invest. Ophthalmol. Vis. Sci. 45, 872-878.
26. Gual, P., Baron, V., Lequoy, V., and Van Obberghen, E. (1998) Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor. Endocrinology 139, 884-893.
27. Vignais, M. L. and Gilman, M. (1999) Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cellfree system. Mol. Cell Biol. 19, 3727-3735.
28. Ozbay, T. and Nahta, R. (2008) A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells. Mol. Cancer Res. 6, 1052-1058.
29. Tan, J. C. and Rabkin, R. (2005) Suppressors of cytokine signaling in health and disease. Pediatr. Nephrol. 20, 567-575.
30. Yoshimura, A., Naka, T., and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465.
31. Ilangumaran, S., Ramanathan, S., and Rottapel, R. (2004) Regulation of the immune system by SOCS family adaptor proteins. Semin. Immunol. 16, 351-365.
32. Shuai, K. (2006) Regulation of cytokine signaling pathways by PIAS proteins. Cell Res. 16, 196-202.
33. Inaba, M., Saito, H., Fujimoto, M., Sumitani, S., Ohkawara, T., Tanaka, T., Kouhara, H., Kasayama, S., Kawase, I., Kishimoto, T., and Naka, T. (2005) Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transduction. Biochem. Biophys. Res. Commun. 328, 953-961.
34. Park, Y., Shon, S. K., Kim, A., Kim, K. I., Yang, Y., Cho, D. H., Lee, M. S., and Lim, J. S. (2007) SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem. Biophys. Res. Commun. 363, 361-367.
35. Evans, M. K., Yu, C. R., Lohani, A., Mahdi, R. M., Liu, X., Trzeciak, A. R., and Egwuagu, C. E. (2007) Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. Oncogene 26, 1941-1948.
36. Lebrun, P. and Van Obberghen, E. (2008) SOCS proteins causing trouble in insulin action. Acta Physiol. (Oxf) 192, 29-36.
37. Nicholson, S. E., Metcalf, D., Sprigg, N. S., Columbus, R., Walker, F., Silva, A., Cary, D., Willson, T. A., Zhang, J. G., Hilton, D. J., Alexander, W. S., and Nicola, N. A. (2005) Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling. Proc. Natl. Acad. Sci. USA 102, 2328-2333.
38. Ben-Zvi, T., Yayon, A., Gertler, A., and Monsonego-Ornan, E. (2006) Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling. J. Cell Sci. 119, 380-387.
39. Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., and Mooney, R. A. (2003) Suppressor of cytokine signaling- 3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746.
40. Dey, B. R., Spence, S. L., Nissley, P., and Furlanetto, R. W. (1998) Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin- like growth factor-I receptor. J. Biol. Chem. 273, 24095-24101.
41. Dey, B. R., Furlanetto, R. W., and Nissley, P. (2000) Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem. Biophys. Res. Commun. 278, 3843.
42. Cacalano, N. A., Sanden, D., and Johnston, J. A. (2001) Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell. Biol. 3, 460-465.
43. Rui, L., Yuan, M., Frantz, D., Shoelson, S., and White, M. F. (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394-42398.
44. Smeets, R. L., Veenbergen, S., Arntz, O. J., Bennink, M. B., Joosten, L. A., van den Berg, W. B., and van de Loo, F. A. (2006) A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthritis Rheum. 54, 1518-1528.
45. Krebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J. G., Starr, R., De Souza, D. P., Hanzinikolas, K., Eyles, J., Connolly, L. M., Simpson, R. J., Nicola, N. A., Nicholson, S. E., Baca, M., Hilton, D. J., and Alexander, W. S. (2002) SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell Biol. 22, 4567-4578.
46. Li, L., Gronning, L. M., Anderson, P. O., Li, S., Edvardsen, K., Johnston, J., Kioussis, D., Shepherd, P. R., and Wang, P. (2004) Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism. J. Biol. Chem. 279, 34107-34114.
47. De Sepulveda, P., Okkenhaug, K., Rose, J. L., Hawley, R. G., Dubreuil, P., and Rottapel, R. (1999) Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J. 18, 904-915.
48. Wauman, J., De Smet, A. S., Catteeuw, D., Belsham, D., and Tavernier, J. (2008) Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways. Mol. Endocrinol. 22, 965-977.
49. Fruchtman, S., Simmons, J. G., Michaylira, C. Z., Miller, M. E., Greenhalgh, C. J., Ney, D. M., and Lund, P. K. (2005) Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G342-G350.
50. Miller, M. E., Michaylira, C. Z., Simmons, J. G., Ney, D. M., Dahly, E. M., Heath, J. K., and Lund, P. K. (2004) Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 127, 570-581.
51. Michaylira, C. Z., Simmons, J. G., Ramocki, N. M., Scull, B. P., McNaughton, K. K., Fuller, C. R., and Lund, P. K. (2006) Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. Am. J. Physiol. Gastrointest. Liver. Physiol. 291, G472-G481.
52. Usenko, T., Eskinazi, D., Correa, P. N., Amato, D., Ben-David, Y., and Axelrad, A. A. (2007) Overexpression of SOCS-2 and SOCS-3 genes reverses erythroid overgrowth and IGF-I hypersensitivity of primary polycythemia vera (PV) cells. Leuk. Lymphoma 48, 134-146.
53. Lieskovska, J., Guo, D., and Derman, E. (2003) Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA. Growth Horm. IGF Res. 13, 26-35.
54. Denson, L. A., Held, M. A., Menon, R. K., Frank, S. J., Parlow, A. F., and Arnold, D. L. (2003) Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G646-G654.
55. Flores-Morales, A., Greenhalgh, C. J., Norstedt, G., and Rico-Bautista, E. (2006) Negative regulation of growth hormone receptor signaling. Mol. Endocrinol. 20, 241-253.
56. Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y., and Furlanetto, R. W. (2001) Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem. 276, 25889-25893.
57. Rui, L., Yuan, M., Frantz, D., Shoelson, S., and White, M. F. (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394-42398.
58. Dey, B. R., Furlanetto, R. W., and Nissley, P. (2000) Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem. Biophys. Res. Commun. 278, 38-43.